1 |
CHEN D, WU P, LIU D, et al. Clinical role of M. pneumoniae typing antibody detected by chemiluminescent immunoassay in the diagnosis of Mycoplasma pneumoniae pneumonia in children[J]. Int Immunopharmacol,2022,112:109196. doi:10.1016/j.intimp.2022.109196
doi: 10.1016/j.intimp.2022.109196
|
2 |
国家卫生健康委员会. 儿童肺炎支原体肺炎诊疗指南(2023年版)[J]. 传染病信息,2023,36(4):291-297.
|
3 |
XIE X Y, ZHOU R Y, DING S A, et al. Emerging trends and concerns in mycoplasma pneumoniae pneumonia among Chinese pediatric population[J]. Pediatr Res,2024,95(6):1388-1390. doi:10.1038/s41390-024-03049-y
doi: 10.1038/s41390-024-03049-y
|
4 |
MEYER S P, SEILER M, TRUCK J, et al. Diagnosis of mycoplasma pneumoniae pneumonia with measurement of specific antibody-secreting cells[J]. Am J Respir Crit Care Med,2019,200(8):1066-1069. doi:10.1164/rccm.201904-0860le
doi: 10.1164/rccm.201904-0860le
|
5 |
CHEN Q, HU T, WU L, et al. Clinical features and biomarkers for early prediction of refractory mycoplasma pneumoniae pneumonia in Children[J]. Emerg Med Int,2024,2024:1-7. doi:10.1155/2024/9328177
doi: 10.1155/2024/9328177
|
6 |
YANG M, MENG F, GAO M, et al. Cytokine signatures associate with disease severity in children with mycoplasma pneumoniae pneumonia[J]. Sci Rep,2019,9(1):17853. doi:10.1038/s41598-019-54313-9
doi: 10.1038/s41598-019-54313-9
|
7 |
ZHAO J, LI Y, ZHANG W. The clinical significance of IL-6 s and IL-27 s in Bronchoalveolar lavage fluids from children with mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2020,20(1):331. doi:10.1186/s12879-020-05017-3
doi: 10.1186/s12879-020-05017-3
|
8 |
ZHANG Z, DOU H, TU P, et al. Serum cytokine profiling reveals different immune response patterns during general and severe Mycoplasma pneumoniae pneumonia[J]. Front Immunol,2022,13:1088725. doi:10.3389/fimmu.2022.1088725
doi: 10.3389/fimmu.2022.1088725
|
9 |
ZHOU L, LI Y, XU Z, et al. Increased Total Serum Immunoglobulin E is likely to cause complications of mycoplasma pneumoniae Pneumonia in Children[J]. Front Cell Infect Microbiol,2021,11:783635. doi:10.3389/fcimb.2021.783635
doi: 10.3389/fcimb.2021.783635
|
10 |
BIAN C, LI S, HUO S, et al. Association of atopy with disease severity in children with mycoplasma pneumoniae pneumonia[J].Front Pediatr,2023,11:1281479. doi:10.3389/fped.2023.1281479
doi: 10.3389/fped.2023.1281479
|
11 |
MA L, YAN J, SONG W, et al. Early peripheral blood lymphocyte subsets and cytokines in predicting the severity of influenza B virus pneumonia in children[J]. Front Cell Infect Microbiol,2023,13:1173362. doi:10.3389/fcimb.2023.1173362
doi: 10.3389/fcimb.2023.1173362
|
12 |
IANNETTA M, BUCCISANO F, FRABONI D, et al. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: A single center study[J]. Sci Rep,2021,11(1):12762. doi:10.1038/s41598-021-90983-0
doi: 10.1038/s41598-021-90983-0
|
13 |
WIK J A, CHOWDHURY A, KOLAN S, et al. Endogenous glutamine is rate-limiting for anti-CD3 and anti-CD28 induced CD4+ T-cell proliferation and glycolytic activity under hypoxia and normoxia[J]. Biochem J,2022,479(11):1221-1235. doi:10.1042/bcj20220144
doi: 10.1042/bcj20220144
|
14 |
BASU D, BASU S, REDDY M, et al. Clinical and laboratory profile of anti-M[J]. Immunohematology,2019,33(4):165-169.
|
15 |
甄乾娜, 张磊, 王兴斌. 外周血T淋巴细胞亚群和细胞因子在儿童肺炎支原体肺炎诊断中的意义[J]. 检验医学与临床,2017,14(8):1060-1062.
|
16 |
ANDREWS L P, VIGNALI K M, SZYMCZAK-WORKMAN A L, et al. A Cre-driven allele-conditioning line to interrogate CD4(+) conventional T cells[J]. Immunity,2021,54(10):2209-2217. doi:10.1016/j.immuni.2021.08.029
doi: 10.1016/j.immuni.2021.08.029
|
17 |
LEE W J, HUANG E Y, TSAI C M, et al. Role of serum mycoplasma pneumoniae IgA, IgM, and IgG in the diagnosis of mycoplasma pneumoniae-Related pneumonia in school-Age Children and adolescents[J]. Clin Vaccine Immunol,2017,24(1):e00471-16. doi:10.1128/cvi.00471-16
doi: 10.1128/cvi.00471-16
|
18 |
ZHANG X, SUN R, JIA W, et al. Clinical characteristics of lung consolidation with mycoplasma pneumoniae pneumonia and risk factors for mycoplasma pneumoniae necrotizing pneumonia in Children[J]. Infect Dis Ther,2024,13(2):329-343. doi:10.1007/s40121-023-00914-x
doi: 10.1007/s40121-023-00914-x
|
19 |
WOOLARD M D, HUDIG D, TABOR L, et al. NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp[J]. Infect Immun,2005,73(10):6742-6751. doi:10.1128/iai.73.10.6742-6751.2005
doi: 10.1128/iai.73.10.6742-6751.2005
|
20 |
GAO M, WANG K, YANG M, et al. Transcriptome analysis of bronchoalveolar lavage fluid from Children with mycoplasma pneumoniae pneumonia reveals natural killer and T Cell-Proliferation Responses[J]. Front Immunol,2018,9:1403. doi:10.3389/fimmu.2018.01403
doi: 10.3389/fimmu.2018.01403
|
21 |
YANG S, LU S, GUO Y, et al. A comparative study of general and severe mycoplasma pneumoniae pneumonia in children[J].BMC Infect Dis,2024,24(1):449. doi:10.1186/s12879-024-09340-x
doi: 10.1186/s12879-024-09340-x
|
22 |
李娜, 穆亚平, 陈静, 等. 淋巴细胞亚群绝对计数对儿童难治性肺炎支原体肺炎的早期预测作用[J]. 中国当代儿科杂志,2019,21(6):511-516.
|
23 |
HUANG X, LI D, LIU F, et al. Clinical significance of D-dimer levels in refractory mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2021,21(1):14. doi:10.1186/s12879-020-05700-5
doi: 10.1186/s12879-020-05700-5
|
24 |
KAWAMATA R, YOKOYAMA K, SATO M, et al. Utility of serum ferritin and lactate dehydrogenase as surrogate markers for steroid therapy for mycoplasma pneumoniae pneumonia[J]. J Infect Chemother,2015,21(11):783-789. doi:10.1016/j.jiac.2015.07.009
doi: 10.1016/j.jiac.2015.07.009
|
25 |
CHANG Q, CHEN H, WU N, et al. Prediction model for severe mycoplasma pneumoniae pneumonia in pediatric patients by admission laboratory indicators[J]. J Trop Pediatr,2022,68(4):fmac059. doi:10.1093/tropej/fmac059
doi: 10.1093/tropej/fmac059
|
26 |
LI L, GUO R, ZOU Y, et al. Construction and Validation of a nomogram model to predict the severity of mycoplasma pneumoniae Pneumonia in Children[J]. J Inflamm Res,2024,17:1183-1191. doi:10.2147/jir.s447569
doi: 10.2147/jir.s447569
|
27 |
ZHANG J, WANG T, LI R, et al. Prediction of risk factors of bronchial mucus plugs in children with mycoplasma pneumoniae pneumonia[J]. BMC Infect Dis,2021,21(1):67. doi:10.1186/s12879-021-05765-w
doi: 10.1186/s12879-021-05765-w
|
28 |
彭力,钟礼立,林琳, 等. 黏蛋白MUC5AC在肺炎支原体肺炎患儿气道中的表达及临床意义[J]. 实用医学杂志,2023,39(20):2618-2622.
|